Anti-IgE: A treatment option in allergic rhinitis?

Background: Allergic rhinitis (AR) is the most common IgE-mediated allergic disease. Multiple clinical trials have demonstrated promising results on the AR treatment with biologics, in particular with the use of omalizumab – an anti-IgE antibody. Omalizumab has also been established in the routine m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaar, Oliver, Gehrt, Francesca, Li, Hansen, Rudhart, Stefan A., Nastev, Alexander, Stuck, Boris A., Hoch, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905705/
https://www.ncbi.nlm.nih.gov/pubmed/33644635
http://dx.doi.org/10.5414/ALX02205E

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905705/
https://www.ncbi.nlm.nih.gov/pubmed/33644635
http://dx.doi.org/10.5414/ALX02205E

Ejemplares similares